PortfoliosLab logoPortfoliosLab logo
BNKE.L vs. CD91.DE
Performance
Return for Risk
Drawdowns
Volatility
Dividends

Performance

BNKE.L vs. CD91.DE - Performance Comparison

The chart below illustrates the hypothetical performance of a £10,000 investment in Lyxor EURO STOXX Banks (DR) UCITS ETF - Acc (BNKE.L) and Amundi NYSE Arca Gold Bugs UCITS ETF Dist (CD91.DE). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Different Trading Currencies

BNKE.L is traded in GBP, while CD91.DE is traded in EUR. To make them comparable, the CD91.DE values have been converted to GBP using the latest available exchange rates.

Returns By Period

In the year-to-date period, BNKE.L achieves a 4.63% return, which is significantly higher than CD91.DE's 1.29% return.


BNKE.L

1D
0.77%
1M
6.68%
YTD
4.63%
6M
11.03%
1Y
45.15%
3Y*
46.04%
5Y*
29.25%
10Y*

CD91.DE

1D
1.04%
1M
-5.79%
YTD
1.29%
6M
8.62%
1Y
71.09%
3Y*
40.38%
5Y*
20.35%
10Y*
13.59%
*Multi-year figures are annualized to reflect compound growth (CAGR)

BNKE.L vs. CD91.DE - Yearly Performance Comparison


2026 (YTD)2025202420232022202120202019
BNKE.L
Lyxor EURO STOXX Banks (DR) UCITS ETF - Acc
4.63%99.94%25.19%27.75%6.62%31.33%-18.12%2.40%
CD91.DE
Amundi NYSE Arca Gold Bugs UCITS ETF Dist
1.29%144.49%15.47%0.38%3.79%-14.54%21.89%8.84%

Correlation

The correlation between BNKE.L and CD91.DE is 0.26, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.26

Correlation (3Y)
Calculated over the trailing 3-year period

0.20

Correlation (5Y)
Calculated over the trailing 5-year period

0.15

Correlation (All Time)
Calculated using the full available price history since Jul 24, 2019

0.09

The correlation between BNKE.L and CD91.DE shifts across timeframes, from 0.09 (all time) to 0.26 (1 year), reflecting how their relationship changes across market environments.

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

BNKE.L vs. CD91.DE — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

BNKE.L
BNKE.L Risk / Return Rank: 5555
Overall Rank
BNKE.L Sharpe Ratio Rank: 5858
Sharpe Ratio Rank
BNKE.L Sortino Ratio Rank: 5656
Sortino Ratio Rank
BNKE.L Omega Ratio Rank: 5252
Omega Ratio Rank
BNKE.L Calmar Ratio Rank: 5555
Calmar Ratio Rank
BNKE.L Martin Ratio Rank: 5252
Martin Ratio Rank

CD91.DE
CD91.DE Risk / Return Rank: 4444
Overall Rank
CD91.DE Sharpe Ratio Rank: 4646
Sharpe Ratio Rank
CD91.DE Sortino Ratio Rank: 4141
Sortino Ratio Rank
CD91.DE Omega Ratio Rank: 4242
Omega Ratio Rank
CD91.DE Calmar Ratio Rank: 5151
Calmar Ratio Rank
CD91.DE Martin Ratio Rank: 4040
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

BNKE.L vs. CD91.DE - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Lyxor EURO STOXX Banks (DR) UCITS ETF - Acc (BNKE.L) and Amundi NYSE Arca Gold Bugs UCITS ETF Dist (CD91.DE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


BNKE.LCD91.DEDifference
Sharpe ratioReturn per unit of total volatility

+0.22

Sortino ratioReturn per unit of downside risk

+0.50

Omega ratioGain probability vs. loss probability

1.32

1.28

+0.04

Calmar ratioReturn relative to maximum drawdown

2.70

2.60

+0.10

Martin ratioReturn relative to average drawdown

8.72

6.48

+2.24

BNKE.L vs. CD91.DE - Sharpe Ratio Comparison

The current BNKE.L Sharpe Ratio is 1.93, which is comparable to the CD91.DE Sharpe Ratio of 1.71. The chart below compares the historical Sharpe Ratios of BNKE.L and CD91.DE, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Sharpe Ratios by Period


BNKE.LCD91.DEDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

1.93

1.71

+0.22

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

1.15

0.59

+0.56

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

0.39

Sharpe Ratio (All Time)

Calculated using the full available price history

0.75

0.09

+0.66

Drawdowns

BNKE.L vs. CD91.DE - Drawdown Comparison

The maximum BNKE.L drawdown since its inception was -48.52%, smaller than the maximum CD91.DE drawdown of -83.29%. Use the drawdown chart below to compare losses from any high point for BNKE.L and CD91.DE.


Loading charts...

Drawdown Indicators


BNKE.LCD91.DEDifference

Max Drawdown

Largest peak-to-trough decline

-48.52%

-83.29%

+34.77%

Max Drawdown (1Y)

Largest decline over 1 year

-16.66%

-27.79%

+11.13%

Max Drawdown (3Y)

Largest decline over 3 years

-18.40%

-27.79%

+9.39%

Max Drawdown (5Y)

Largest decline over 5 years

-34.21%

-37.37%

+3.16%

Max Drawdown (10Y)

Largest decline over 10 years

-53.47%

Current Drawdown

Current decline from peak

-1.62%

-24.23%

+22.61%

Average Drawdown

Average peak-to-trough decline

-10.40%

-47.42%

+37.02%

Ulcer Index

Depth and duration of drawdowns from previous peaks

5.17%

11.15%

-5.98%

Volatility

BNKE.L vs. CD91.DE - Volatility Comparison

The current volatility for Lyxor EURO STOXX Banks (DR) UCITS ETF - Acc (BNKE.L) is 6.10%, while Amundi NYSE Arca Gold Bugs UCITS ETF Dist (CD91.DE) has a volatility of 13.34%. This indicates that BNKE.L experiences smaller price fluctuations and is considered to be less risky than CD91.DE based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


BNKE.LCD91.DEDifference

Volatility (1M)

Calculated over the trailing 1-month period

6.10%

13.34%

-7.24%

Volatility (6M)

Calculated over the trailing 6-month period

18.62%

33.66%

-15.04%

Volatility (1Y)

Calculated over the trailing 1-year period

23.28%

42.22%

-18.94%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

25.45%

33.96%

-8.51%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

29.62%

34.76%

-5.14%

BNKE.L vs. CD91.DE - Expense Ratio Comparison

BNKE.L has a 0.30% expense ratio, which is lower than CD91.DE's 0.65% expense ratio.


Dividends

BNKE.L vs. CD91.DE - Dividend Comparison

BNKE.L has not paid dividends to shareholders, while CD91.DE's dividend yield for the trailing twelve months is around 0.13%.


PositionTTM202520242023202220212020201920182017
BNKE.L
Lyxor EURO STOXX Banks (DR) UCITS ETF - Acc
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
CD91.DE
Amundi NYSE Arca Gold Bugs UCITS ETF Dist
0.13%0.14%0.31%2.37%1.05%0.46%0.14%0.30%0.00%0.57%

Frequently Asked Questions


BNKE.L and CD91.DE have a correlation of 0.26, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

On fees, BNKE.L is cheaper at 0.30% per year. The better choice depends on whether you care most about return, fees, risk, or income.

BNKE.L is cheaper with a 0.30% expense ratio, compared with 0.65% for CD91.DE.

BNKE.L is categorized as Financials Equities, while CD91.DE is Gold. BNKE.L tracks MSCI World/Financials NR USD, while CD91.DE tracks NYSE Arca Gold BUGS. Their fees differ too: 0.30% for BNKE.L and 0.65% for CD91.DE.

Portfolio Optimizer

Find the right allocation for BNKE.L and CD91.DE

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer